Latest return on equity
Nurix Therapeutics Return on equity
Nurix Therapeutics (NRIX) return on equity with its verified observation date.
Direct answer
Nurix Therapeutics's return on equity is -80.3%.
The verified market snapshot reports -80.3%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 19, 2026.
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -80.3%
Explore related company data
View Nurix Therapeutics's market capitalizationView Nurix Therapeutics's price-to-book ratioView Nurix Therapeutics's 52-week price rangeView Nurix Therapeutics's revenue growthView Nurix Therapeutics's profit marginView Nurix Therapeutics's debt-to-equity ratioView all Nurix Therapeutics key metricsReturn to Nurix Therapeutics profile